A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects

NCT02007941 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

NCT04952506 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

NCT04906798 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

NCT04906785 ·Status: UNKNOWN ·Phase: PHASE1

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers

NCT04867200 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability and PK of SK-08

NCT07021157 ·Status: RECRUITING ·Phase: PHASE1

A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers

NCT01578928 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344

NCT04673695 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment

NCT04859439 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease

NCT06248567 ·Status: COMPLETED ·Phase: PHASE1

The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

NCT04195919 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105

NCT03043482 ·Status: COMPLETED ·Phase: PHASE1

Medicine-induced Cardiac Hemodialysis on COVID-19

NCT05711810 ·Status: COMPLETED ·Phase: PHASE4

Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects

NCT05948059 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)

NCT06814119 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease

NCT02837237 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects

NCT03235375 ·Status: COMPLETED ·Phase: PHASE1

CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis

NCT03428594 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease

NCT03913000 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4

NCT04707573 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis

NCT00858637 ·Status: COMPLETED ·Phase: PHASE3

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

NCT04678505 ·Status: TERMINATED ·Phase: PHASE1

Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis

NCT03710291 ·Status: TERMINATED ·Phase: PHASE3

A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight

NCT05515432 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

NCT02603497 ·Status: COMPLETED ·Phase: PHASE1